Black/African Americans have the highest mortality rate of any racial and ethnic group for all cancers combined and for most major cancers.1
- From 2017–20211,
- Black/African American males were 1.8 times and 1.7 times, respectively, more likely to have new cases of stomach and prostate cancer than non-Hispanic white males.
- Black/African American females were more than two times as likely to be diagnosed with stomach cancer than non-Hispanic white females.
- From 2018–20221,
- Black/African American males were 2.4 times and 2.1 times, respectively, more likely to die from stomach and prostate cancer than non-Hispanic white males.
- Black/African American females were 2.4 times and 2.0 times, respectively, more likely to die from stomach and uterine cancer than non-Hispanic white females.
- Black/African Americans have lower 5-year cancer survival rates for most cancer sites than non-Hispanic whites.1
- Black/African American females have similar rates of breast cancer incidence as non-Hispanic white females, but from 2018–2022 they were 40% more likely to die from breast cancer than non-Hispanic white females.1
Diagnosis
Cancer among adults age 18 and over, age-adjusted percentage, 2023 | |||
---|---|---|---|
Cancer | Non-Hispanic Black | Non-Hispanic White | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 5.7 | 13.0 | 0.4 |
Breast | 1.6 | 2.2 | 0.7 |
Cervical (women) | 0.6 | 1.2 | 0.5 |
Prostate (men) | 3.7 | 3.0 | 1.2 |
Any skin | 0.2 | 5.3 | 0.0 |
Top Cancer Sites for Black/African American Males (2017–2021)
Cancer Incidence among males, rate per 100,000 population, 2017–2021 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Males | Non-Hispanic White Males | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 526.5 | 510.7 | 1.0 |
Colon & Rectum | 49.4 | 42.0 | 1.2 |
Esophagus | 5.2 | 8.3 | 0.6 |
Kidney | 24.7 | 22.9 | 1.1 |
Liver & IBD | 16.6 | 11.2 | 1.5 |
Lung | 66.5 | 60.0 | 1.1 |
Oral Cavity & Pharynx | 12.7 | 20.1 | 0.6 |
Pancreas | 17.7 | 16.0 | 1.1 |
Prostate | 188.7 | 114.9 | 1.6 |
Stomach | 13.2 | 7.5 | 1.8 |
Top Cancer Sites for Black/African American Females (2017–2021)
Cancer incidence among females, rate per 100,000 population, 2017–2021 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Females | Non-Hispanic White Females | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 403.1 | 447.0 | 0.9 |
Breast | 129.3 | 139.0 | 0.9 |
Cervical | 8.7 | 6.9 | 1.3 |
Colon & Rectum | 36.8 | 32.4 | 1.1 |
Kidney | 12.6 | 11.1 | 1.1 |
Liver & IBD | 5.5 | 4.3 | 1.3 |
Lung | 43.2 | 52.2 | 0.8 |
Pancreas | 15.1 | 11.9 | 1.3 |
Stomach | 8.0 | 3.7 | 2.2 |
Uterus | 30.2 | 27.7 | 1.1 |
5-Year Survival Rate
5-year survival rate among males by cancer site, percentage, 2014–2020 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Males | Non-Hispanic White Males | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 66.8 | 68.7 | 1.0 |
Colon & Rectum | 57.3 | 65.2 | 0.9 |
Kidney | 75.5 | 79.0 | 1.0 |
Liver & IBD | 19.1 | 20.5 | 0.9 |
Lung | 20.1 | 22.6 | 0.9 |
Pancreas | 10.4 | 12.8 | 0.8 |
Prostate | 97.0 | 98.0 | 1.0 |
Stomach | 31.9 | 32.6 | 1.0 |
5-year survival rate among females, percentage, 2014–2020 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Females | Non-Hispanic White Females | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 63.4 | 71.3 | 0.9 |
Breast | 83.8 | 93.0 | 0.9 |
Cervical | 58.1 | 67.8 | 0.9 |
Colon & Rectum | 62.0 | 66.1 | 0.9 |
Kidney | 79.5 | 80.9 | 1.0 |
Liver & IBD | 23.6 | 21.1 | 1.1 |
Lung | 28.2 | 30.8 | 0.9 |
Pancreas | 12.0 | 12.3 | 1.0 |
Stomach | 44.5 | 44.1 | 1.0 |
Uterus | 63.0 | 84.2 | 0.7 |
Death Rate
5-year mortality among males, age-adjusted rate per 100,000 population, 2018–2022 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Males | Non-Hispanic White Males | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 208.3 | 179.0 | 1.2 |
Colon & Rectum | 21.3 | 15.2 | 1.4 |
Liver & IBD | 12.3 | 8.4 | 1.5 |
Lung | 46.7 | 41.2 | 1.1 |
Pancreas | 15.3 | 13.2 | 1.2 |
Prostate | 37.2 | 18.1 | 2.1 |
Stomach | 6.6 | 2.8 | 2.4 |
5-year mortality among females, age-adjusted rate per 100,000 population, 2018–2022 | |||
---|---|---|---|
Cancer | Non-Hispanic Black Females | Non-Hispanic White Females | Non-Hispanic Black / Non-Hispanic White Ratio |
All Sites | 144.7 | 131.0 | 1.1 |
Breast | 26.8 | 19.4 | 1.4 |
Cervical | 3.2 | 2.1 | 1.5 |
Colon & Rectum | 13.5 | 10.9 | 1.2 |
Liver & IBD | 4.6 | 3.8 | 1.2 |
Pancreas | 12.3 | 9.8 | 1.3 |
Stomach | 3.3 | 1.4 | 2.4 |
Uterus | 9.5 | 4.7 | 2.0 |
Screening
Breast Cancer
Women ages 50–74 who had a mammogram in the past 2 years, percentage, 2021 | ||
---|---|---|
Non-Hispanic Black Women | Non-Hispanic White Women | Non-Hispanic Black / Non-Hispanic White Ratio |
81.5 | 76.1 | 1.1 |
Cervical Cancer
Women ages 21–65 who had a Pap smear in the past 3 years or human papillomavirus vaccines in the last 5 years, percentage, 2021 | ||
---|---|---|
Non-Hispanic Black Women | Non-Hispanic White Women | Non-Hispanic Black / Non-Hispanic White Ratio |
74.4 | 79.9 | 0.9 |
Colorectal Cancer
Adults ages 50–75 who received any type of colorectal cancer screening, percentage, 2021 | ||
---|---|---|
Non-Hispanic Black Women | Non-Hispanic White Women | Non-Hispanic Black / Non-Hispanic White Ratio |
71.7 | 74.2 | 1.0 |
1SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. (back)
Last Edited: 01/16/2025